117 related articles for article (PubMed ID: 15504291)
1. [The effect of angiotensin II type 1 receptor blocker valsartan in preventing hepatic fibrosis induced by dimethylnitrosamine in rats].
Shen FJ; Zhu YK; Jia JD; Ma H; Wang BE
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):605-8. PubMed ID: 15504291
[TBL] [Abstract][Full Text] [Related]
2. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
3. [Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
Gong ZJ; Song SL; Huang YQ; Ruan P
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):737-40. PubMed ID: 15619341
[TBL] [Abstract][Full Text] [Related]
4. [Dynamic evolution of MMP-13, TIMP-1, type I and III collagen and their interaction in experimental liver fibrosis].
Zhu YK; Wang BE; Shen FJ; Wang AM; Jia JD; Ma H
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):612-5. PubMed ID: 15504294
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].
Zhao XY; Wang BE; Wang TL; Li XM
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2563-6. PubMed ID: 17198567
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
Tachikawa H; Kodama M; Hui L; Yoshida T; Hayashi M; Abe S; Kashimura T; Kato K; Hanawa H; Watanabe K; Nakazawa M; Aizawa Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
[TBL] [Abstract][Full Text] [Related]
8. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
9. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
[TBL] [Abstract][Full Text] [Related]
10. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
11. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
[TBL] [Abstract][Full Text] [Related]
12. [Expression of angiotensin converting enzyme and angiotensin II receptor in rabbits with hyperthyroid cardiomyopathy].
Zhang A; Deng W; Yin YH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):712-6. PubMed ID: 18093424
[TBL] [Abstract][Full Text] [Related]
13. [The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice].
Xie XW; Zhao P
Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):770-3. PubMed ID: 15634486
[TBL] [Abstract][Full Text] [Related]
14. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action.
Hu QW; Liu GT
Life Sci; 2006 Jul; 79(6):606-12. PubMed ID: 16603200
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of idoxifene on hepatic fibrosis in rats.
Zhou YJ; Yin DM; Chen HS; Shi JH; Sha BX; Wang X
Acta Pharmacol Sin; 2005 May; 26(5):581-6. PubMed ID: 15842777
[TBL] [Abstract][Full Text] [Related]
16. [Dynamic evolution of MMP-2 gene expression and its enzymatic activities in experimental liver fibrosis].
Zhu YK; Wang BE; Shen FJ; Jia JD; Ma H
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):509-12. PubMed ID: 16042886
[TBL] [Abstract][Full Text] [Related]
17. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
[TBL] [Abstract][Full Text] [Related]
18. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
[TBL] [Abstract][Full Text] [Related]
19. The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats.
Lee ES; Lee HE; Shin JY; Yoon S; Moon JO
J Pharm Pharmacol; 2003 Aug; 55(8):1169-74. PubMed ID: 12956909
[TBL] [Abstract][Full Text] [Related]
20. [Effect of ACE-I and AT-1 receptor blocker on the progression of CCl(4)-inducing rat hepatic fibrogenesis].
Li X; Meng Y; Zhang ZS; Yang XS; Wu PS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1241-5. PubMed ID: 12930639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
